Ozempic vs Mounjaro: Which Weight-Loss Peptide Is Better?

If you've decided a weight-loss peptide might be right for you, the next question is almost always the same: Ozempic or Mounjaro? It's a fair question with a genuinely interesting answer — there's now a head-to-head trial — but also one where "which is better?" quietly misses the point. The honest version is that one is, on average, more powerful, and the right choice still depends on you. Here's how they actually compare.

First, the names

The confusion starts with branding, so let's clear it up. There are really only two molecules, each sold under different names depending on dose and approved use:

• Semaglutide → Ozempic (diabetes) and Wegovy (weight management).
• Tirzepatide → Mounjaro (diabetes) and Zepbound (weight management).

Both are injectable peptides that copy gut hormones to reduce appetite. So "Ozempic vs Mounjaro" is really semaglutide vs tirzepatide.

The key difference: one hormone or two

This is the heart of it. Semaglutide mimics a single gut hormone, GLP-1. Tirzepatide is a dual agonist — it mimics GLP-1 and GIP, a second incretin hormone. That extra mechanism appears to be why tirzepatide tends to be the more powerful of the two for weight loss.

What does the head-to-head trial show?

For years the comparison relied on separate trials: semaglutide averaged about 14.9% body-weight loss in STEP 1 ³, tirzepatide up to about 20.9% in SURMOUNT-1 ². Comparing across different studies is imperfect, so the real news is SURMOUNT-5, which put them head-to-head in the same trial: over 72 weeks, tirzepatide produced significantly greater weight loss and waist-circumference reduction than semaglutide ¹. Interestingly, gut side effects severe enough to stop treatment were slightly less common with tirzepatide. So on the headline numbers, tirzepatide is the stronger performer.

So why isn't tirzepatide just "the answer"?

Because the average hides what matters to you. A few honest reasons the "weaker" option is often the right one:

• Tolerance is individual. Some people get on far better with one than the other; the best drug is the one you can actually stay on comfortably.
• You may not need the maximum. If 15% gets you to your health goals, "more powerful" is irrelevant.
• Cost and availability differ and change over time — including here in Thailand, where both are prescription-only and worth sourcing carefully.
• Your health profile matters. Other conditions and medications can tip the choice, and both share the same cautions (the thyroid and pancreatitis history, pregnancy).

This is exactly why these are prescription medicines, not a pick-the-stronger-one purchase. A prescriber weighs all of the above — the league-table winner isn't automatically your winner.

What they have in common

Don't lose sight of how similar they are. Both reduce appetite by copying gut hormones; both are weekly injections; both commonly cause nausea and other gut effects, especially as the dose climbs; both carry the thyroid warning; and — crucially — both tend to see weight regained if you simply stop ⁴. Whichever you choose, the durable result comes from the habits built alongside it (protein, resistance training, sleep), not from the molecule alone. We cover that, and the side effects in depth, in our main GLP-1 guide.

What we see at the clinic

At our clinic in Pattaya, "Ozempic or Mounjaro?" is one of the most common questions from visitors weighing weight-loss options. Our answer is rarely a flat "this one" — it's to start with your actual health picture (weight history, blood sugar, the rest of a proper baseline) and your tolerance and goals, then match the medicine to the person. We're also candid that the newest, most powerful option isn't always the wisest first step, and that both belong in a plan that includes the unglamorous foundations. And we're firm on sourcing: genuine product through a licensed provider, never a counterfeit pen.

Common questions

Is Mounjaro better than Ozempic? For weight loss on average, yes — tirzepatide beat semaglutide head-to-head in SURMOUNT-5 ¹. But "better on average" isn't "better for everyone": tolerance, cost, availability and your health all matter.

How much more weight will I lose on tirzepatide? Roughly, trials average about 20% for tirzepatide versus about 15% for semaglutide ¹²³ — but the spread between individuals is large, so treat those as ballpark, not a promise.

Do they have different side effects? They're broadly similar — mostly gut-related (nausea, etc.) — and share the thyroid warning. In the head-to-head trial, fewer people stopped tirzepatide for gut side effects, but individual experience varies.

Can I switch from one to the other? Sometimes, for tolerance or results — but it's a decision to make with your prescriber, who manages the dosing transition. It's not something to improvise.

Key takeaway

Ozempic (semaglutide) and Mounjaro (tirzepatide) are close cousins that differ in one big way: tirzepatide adds a second hormone and, head-to-head, delivered greater average weight loss. But the better average drug isn't automatically the better drug for you — that depends on tolerance, cost, availability and your health, which is why it's a prescriber's decision, not a checkout choice. Whichever you land on, it's a tool, and the lasting result still comes from what you build around it.